Article Details

Eucure Biopharma Announces Breakthrough Phase I Results for Anti-CTLA-4 Therapy in ...

Retrieved on: 2021-03-22 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Eucure Biopharma Announces Breakthrough Phase I Results for Anti-CTLA-4 Therapy in .... View article details on hiswai:

Excerpt

BOSTON and BEIJING, March 22, 2021 /PRNewswire/ -- Eucure Biopharma, a subsidiary of Biocytogen focused on developing proprietary ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo